Methods and compositions for preventing or minimizing epithelial-mesenchymal transition
TW201618764A
Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
TW201305098A
Compounds and pharmaceutical compositions for uses in diabetes
KR20120090011A
Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
KR20120024696A
Substituted aromatic compounds and pharmaceutical uses thereof
CA2708679A1
Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
WO2009055932A1
Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis
WO2008131547A1
'triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives'
NZ563245A
Triazine compounds and compositions thereof for the treatment of cancers
CA2608314A1
Compounds and their use for the treatment of autoimmune diseases
AP200703968A0
Medium-chain length fatty alcohols as stimulators of hematopoiesis
AU2005279615A1
2,4,6-triamino-s-triazine-based compounds which bind to the tail (Fc) portion of immunoglobulins and their use
AP200703939A0
Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
BRPI0412828A
preparation of metal salts of medium chain fatty acids
BRPI0407276A
fatty acids, glycerides and analogues of medium chain length as erythropoiesis stimulants
TNSN03022A1
Method for treatment of inflammation
US6746608B2
Use of adsorbent polymer particles in DNA separation
CA2444463A1
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
